NCT01757535 2025-07-08
QUAZAR AML-001
Celgene
Phase 3 Completed
Clinical Trials
3 trialsNCT03703375 2024-07-08
Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma
Celgene
Phase 3 Active not recruiting
NCT04173533 2024-05-14
AMADEUS
University of Birmingham
Phase 3 Active not recruiting